top of page

Qvella Corporation


Qvella, a diagnostics company established in 2009 by a team of scientists and engineers, aims to speed up microbiology results significantly. Their goal is to transform sepsis management by quickly providing actionable results, ultimately saving lives. Qvella's innovative Field Activated Sample Treatment (FAST) technology allows for swift detection of infectious agents in whole blood through a unique sample preparation method. When combined with Antibiotic Stewardship programs, now widely adopted by major medical centers, this technology facilitates timely clinical decisions. This, in turn, leads to better patient outcomes, shorter hospital stays, fewer side effects, and lower treatment costs.

bottom of page